Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The 2010 Annual Conference of the Canadian Pain Society.

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC2886994 | biostudies-literature | 2010 Mar-Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

The 2010 Annual Conference of the Canadian Pain Society.

Pain research & management 20100301 2

PMID: 20458375

Similar Datasets

Canadian Paediatric Society 92nd Annual Conference: Abstracts

Project description: Not available

| S-EPMC4472060 | biostudies-literature

36th Annual Scientific Meeting of the Canadian Pain Society: Abstracts

Project description: Not available

| S-EPMC4447163 | biostudies-literature

First annual Canadian Cardiac Oncology Network conference.

Project description:The inaugural Canadian Cardiac Oncology Network conference was held at the Ottawa Convention Centre, Ottawa, Ontario, May 13, 2011. The learning objectives of the meeting were tounderstand and appreciate the importance of cardiac toxicity in the treatment of cancer patients.review current guidelines, recommendations, and ways to prevent and treat cardiac toxicity in cancer patients.develop potential research initiatives and collaboration across Canada.Although the cardiac toxicities associated with conventional systemic therapy agents are well established, the short- and long-term cardiac toxicities associated with targeted agents are less understood. In addition, the effects of exposing patients to multiple targeted therapies, and potentially compounding multiple cardiac toxicities, are unknown. This meeting report includes highlights from presentations at the conference.

| S-EPMC3224031 | biostudies-other

Canadian Spine Society : 20th Annual Scientific Conference, Fairmont Chateau Whistler, 4599 Chateau Boulevard, Whistler, BC, Feb. 26–29, 2020

Project description: Not available

| S-EPMC7458670 | biostudies-literature

2020 Annual Conference Conference Annuelle.

Project description: Not available

| S-EPMC9632078 | biostudies-literature

Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20-22 February 2020.

Project description:Introduction: There are a lack of established guidelines for the surveillance of high-risk cutaneous melanoma patients following initial therapy. We describe a novel approach to the development of a national expert recommendation statement on high-risk melanoma surveillance (HRS). Methods: A consensus-based, live, online voting process was undertaken at the 13th and 14th annual Canadian Melanoma Conferences (CMC) to collect expert opinions relating to "who, what, where, and when" HRS should be conducted. Initial opinions were gathered via audience participation software and used as the basis for a second iterative questionnaire distributed online to attendees from the 13th CMC and to identified melanoma specialists from across Canada. A third questionnaire was disseminated in a similar fashion to conduct a final vote on HRS that could be implemented. Results: The majority of respondents from the first two iterative surveys agreed on stages IIB to IV as high risk. Surveillance should be conducted by an appropriate specialist, irrespective of association to a cancer centre. Frequency and modality of surveillance favoured biannual visits and Positron Emission Tomography Computed Tomography (PET/CT) with brain magnetic resonance imaging (MRI) among the systemic imaging modalities available. No consensus was initially reached regarding the frequency of systemic imaging and ultrasound of nodal basins (US). The third iterative survey resolved major areas of disagreement. A 5-year surveillance schedule was voted on with 92% of conference members in agreement. Conclusion: This final recommendation was established following 92% overall agreement among the 2020 CMC attendees.

| S-EPMC8161801 | biostudies-literature

62nd Annual Conference of the Indian Society of Gastroenterology, February 10th - 13th, 2022, Pune.

Project description: Not available

| S-EPMC8934723 | biostudies-literature

IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.

Project description:The 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics international conferences, and the 2010 Annual Meeting of The Antibody Society, organized by IBC Life Sciences with contributions from The Antibody Society and two Scientific Advisory Boards, were held December 5-9, 2010 in San Diego, CA. The conferences were organized with a focus on antibody engineering only on the first day and a joint engineering/therapeutics session on the last day. Delegates could select from presentations that occurred in two simultaneous sessions on days 2 and 3. Day 1 included presentations on neutralizing antibodies and the identification of vaccine targets, as well as a historical overview of 20 years of phage display utilization. Topics presented in the Antibody Engineering sessions on day 2 and 3 included antibody biosynthesis, structure and stability; antibodies in a complex environment; antibody half-life; and targeted nanoparticle therapeutics. In the Antibody Therapeutics sessions on days 2 and 3, preclinical and early stage development and clinical updates of antibody therapeutics, including TRX518, SYM004, MM111, PRO140, CVX-241, ASG-5ME, U3-1287 (AMG888), R1507 and trastuzumab emtansine, were discussed, and perspectives were provided on the development of biosimilar and biobetter antibodies, including coverage of regulatory and intellectual property issues. The joint engineering/therapeutics session on the last day focused on bispecific and next-generation antibodies.

| S-EPMC3092615 | biostudies-literature

Abstract Proceedings of the 38th Annual Canadian Association of Psychosocial Oncology (CAPO) Conference, June 2023.

Project description:On behalf of the Canadian Association of Psychosocial Oncology, we are pleased to present the Abstracts from the 2023 Annual Conference, titled "Co-designing Psychosocial Oncology: Optimizing Outcomes for All". The conference was held in Montreal from 20 June 2023 to 22 June 2023. This conference brought together key stakeholders including multidisciplinary professionals from nursing, psychology, psychiatry, social work, spiritual care, nutrition, medicine, rehabilitation medicine, occupational health and radiation therapy for both adult and pediatric populations. Participants included clinicians, researchers, educators in cancer care, community-based organizations and patient representatives. Patients, caregivers and family members presented abstracts that spoke to their role in managing cancer experiences and care. Over one hundred (100) abstracts were selected for presentation as symposia, 20-min oral presentations, 10-min oral presentations, 90-min workshops and poster presentations. We congratulate all the presenters on their research work and contribution.

| S-EPMC10378175 | biostudies-literature

6th Annual Conference of the Neuropathology Society of India (NPSICON) - Meeting Abstracts: February 23-25, 2023.

Project description:The 6th Annual conference of the Neuropathology Society of India, (NPSICON 2023) was held in a virtual mode, from 23rd to 25th February 2023, hosted by the Division of Neuropathology, Department of Pathology, Christian Medical College Vellore. Dr Geeta Chacko was the organizing Chairperson. The pre-conference workshop was on Fluorescence in situ hybridization with nearly 90 registrants. The workshop was conducted by NIMHANS Bangalore with Dr Shilpa Rao, Dr Vaishali Suri, Dr Vani Santosh and Dr Geeta Chacko as resource persons. There were 253 National registrants and 7 International registrations. The conference had participation from reputed national (34) and international (8) faculty and covered a wide range of topics in both neoplastic and non-neoplastic Neuropathology including sessions on perinatal pathology, epilepsy, neuromuscular pathology and several sessions in Neurooncology. There were five symposiums with several sessions of cases-based discussion. The first Prof Ashru K Banerjee oration was delivered by Dr Kenneth Aldape, from NIH Bethesda on: "Practical Aspects of Methylation-Based Diagnostics in Central Nervous System Tumors". The first Prof SK Shankar oration was delivered by Dr Avindra Nath, NIH Bethesda on "Neuropathology of two pandemics: AIDS and COVID". The Presidential oration was delivered by Dr Chitra Sarkar. The key note speakers included Dr Monika Hofer, Dr David Capper, Dr Takashi Komori and Dr Maysa Husseini. There were 28 papers for oral presentation and 38 posters. A highlight of the conference was a lively Quiz competition, which was held as the penultimate session. Despite being a virtual conference, there was active participation from all the delegates and the conference was very well received.

| S-EPMC10280271 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data